Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-329694

Chief Executive Officer acquired 84,810 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2026-07-30 Exercise or conversion : show line 1 in the form +50,021 821,703 D
2026-07-31 Exercise or conversion : show line 2 in the form +34,789 856,492 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-07-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −50,021 700,295 D
2026-07-31 Exercise or conversion : show line 4 in the form Restricted Stock Units −34,789 347,886 D
Loading xslF345X06/ownership.xml…